DOI:
10.1055/s-00000004
Aktuelle Neurologie
LinksClose Window
References
Sieb JP, Köhler W.
Benefits from sustained release pyridostigmine Bromide in Myasthenia gravis: Results of a prospective multicenter open label trial.
Clin Neurol Neurosurg 2010; 112: 781-784
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.